NCT01369433 2020-09-01A Rollover Protocol to Allow Continued Access to Tivozanib (AV 951) for Subjects Enrolled in Other Tivozanib ProtocolsAVEO Pharmaceuticals, Inc.Phase NA Terminated225 enrolled 7 charts
NCT00970411 2017-01-05Study of KRN951 in Patients With Solid TumorsKyowa Kirin Co., Ltd.Phase 1 Completed12 enrolled